Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
B-Cell-Targeted Therapies for Black vs White Americans with Relapsing Multiple Sclerosis.
Journal: Ethnicity & disease
Published: September 15, 2025
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.
Journal: Neurology and therapy
Published: December 20, 2022
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
Journal: The Journal of clinical investigation
Published: July 13, 2022
Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.
Journal: Scientific reports
Published: November 02, 2021
Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Journal: Advances in therapy
Published: June 23, 2021
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Journal: Advances in therapy
Published: January 26, 2021
A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis.
Journal: Molecular imaging and biology
Published: May 13, 2020
Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: January 07, 2020
Black African and Latino/a identity correlates with increased plasmablasts in MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 13, 2018
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Journal: The New England journal of medicine
Published: August 30, 2018
Last Updated: 09/26/2026